Viewing Study NCT03208556


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-29 @ 10:12 PM
Study NCT ID: NCT03208556
Status: UNKNOWN
Last Update Posted: 2017-09-14
First Post: 2017-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module